Phase II/III multicentre randomised controlled trial evaluating a strategy of primary surgery and adjuvant chemotherapy versus peri-operative chemotherapy for resectable gastric signet ring cell adenocarcinomas – PRODIGE 19 – FFCD1103 – ADCI002

The Impact of Perioperative Chemotherapy on Survival in Patients With Gastric Signet Ring Cell Adenocarcinoma

(2011) Mathieu Messager et al.   ANNALS OF SURGERY

Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial

(2011) Marc Ychou et al.   JOURNAL OF CLINICAL ONCOLOGY

Is Pretreatment Endoscopic Biopsy a Good Predictor of Signet Ring Cell Histology in Gastric Carcinoma?

(2011) Guillaume Piessen et al.   WORLD JOURNAL OF SURGERY

A Multicentric Western Analysis of Prognostic Factors in Advanced, Node-Negative Gastric Cancer Patients

(2010) Gian Luca Baiocchi et al.   ANNALS OF SURGERY

Signet Ring Cell Histology is an Independent Predictor of Poor Prognosis in Gastric Adenocarcinoma Regardless of Tumoral Clinical Presentation

(2009) Guillaume Piessen et al.   ANNALS OF SURGERY

Stomach Carcinoma Incidence Patterns in the United States by Histologic Type and Anatomic Site

(2009) H. Wu et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Cancérologie digestive : pratiques chirurgicales

(2009)   JOURNAL DE CHIRURGIE

Early Metabolic Response Evaluation by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography Allows In vivo Testing of Chemosensitivity in Gastric Cancer: Long-term Results of a Prospective Study

(2008) K. Ott et al.   CLINICAL CANCER RESEARCH